Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”

Sieta T. de Vries; Noral Huda S. Al-Mugoter; Irena Petkoska; Stefan Verweij; André J.A. Elferink; Peter G.M. Mol

doi:10.1007/s40258-023-00850-4

Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”

Sieta T. de Vries, Noral Huda S. Al-Mugoter, Irena Petkoska, Stefan Verweij, André J.A. Elferink, Peter G.M. Mol^*

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

55 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	123-124
Aantal pagina's	2
Tijdschrift	Applied Health Economics and Health Policy
Volume	22
Nummer van het tijdschrift	1
DOI's	https://doi.org/10.1007/s40258-023-00850-4
Status	Published - jan.-2024

Toegang tot document

10.1007/s40258-023-00850-4

Comment on- “The Assessment of Patient‑Reported Outcomes for the Authorisation of Medicines in Europe- A Review of European Public Assessment Reports from 2017 to 2022”Final publisher's version, 320 KBLicentie: Taverne

Handle.net

Permanente koppeling

Andere bestanden en links

Link naar publicatie in Scopus

Citeer dit

de Vries, S. T., Al-Mugoter, N. H. S., Petkoska, I., Verweij, S., Elferink, A. J. A., & Mol, P. G. M. (2024). Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”. Applied Health Economics and Health Policy, 22(1), 123-124. https://doi.org/10.1007/s40258-023-00850-4

@article{6c77515bd6fd4258b40d1bd919d6df77,

title = "Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”",

author = "{de Vries}, {Sieta T.} and Al-Mugoter, {Noral Huda S.} and Irena Petkoska and Stefan Verweij and Elferink, {Andr{\'e} J.A.} and Mol, {Peter G.M.}",

year = "2024",

month = jan,

doi = "10.1007/s40258-023-00850-4",

language = "English",

volume = "22",

pages = "123--124",

journal = "Applied Health Economics and Health Policy",

issn = "1175-5652",

publisher = "Springer International Publishing AG",

number = "1",

}

de Vries, ST, Al-Mugoter, NHS, Petkoska, I, Verweij, S, Elferink, AJA & Mol, PGM 2024, 'Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”', Applied Health Economics and Health Policy, vol. 22, nr. 1, blz. 123-124. https://doi.org/10.1007/s40258-023-00850-4

Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”. / de Vries, Sieta T.; Al-Mugoter, Noral Huda S.; Petkoska, Irena et al.
In: Applied Health Economics and Health Policy, Vol. 22, Nr. 1, 01.2024, blz. 123-124.

Onderzoeksoutput › Academic › peer review

TY - JOUR

T1 - Comment on

T2 - “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”

AU - de Vries, Sieta T.

AU - Al-Mugoter, Noral Huda S.

AU - Petkoska, Irena

AU - Verweij, Stefan

AU - Elferink, André J.A.

AU - Mol, Peter G.M.

PY - 2024/1

Y1 - 2024/1

UR - http://www.scopus.com/inward/record.url?scp=85176798138&partnerID=8YFLogxK

U2 - 10.1007/s40258-023-00850-4

DO - 10.1007/s40258-023-00850-4

M3 - Letter

C2 - 37971664

AN - SCOPUS:85176798138

SN - 1175-5652

VL - 22

SP - 123

EP - 124

JO - Applied Health Economics and Health Policy

JF - Applied Health Economics and Health Policy

IS - 1

ER -